Regatta Capital Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.27M Sell
10,452
-113
-1% -$25.1K 0.34% 51
2025
Q4
$2.41M Sell
10,565
-513
-5% -$117K 0.36% 42
2025
Q3
$2.57M Sell
11,078
-390
-3% -$79.4K 0.41% 42
2025
Q2
$2.13M Buy
11,468
+107
+0.9% +$19.9K 0.37% 48
2025
Q1
$2.38M Sell
11,361
-260
-2% -$50.5K 0.46% 38
2024
Q4
$2.06M Buy
11,621
+136
+1% +$25K 0.4% 43
2024
Q3
$2.27M Sell
11,485
-295
-3% -$55.1K 0.44% 43
2024
Q2
$2.02M Sell
11,780
-692
-6% -$115K 0.44% 45
2024
Q1
$2.27M Buy
12,472
+20
+0.2% +$3.45K 0.51% 42
2023
Q4
$1.93M Buy
12,452
+44
+0.4% +$6.42K 0.51% 45
2023
Q3
$1.85M Sell
12,408
-207
-2% -$30.4K 0.59% 35
2023
Q2
$1.7M Sell
12,615
-530
-4% -$77.7K 0.54% 38
2023
Q1
$2.12M Hold
13,145
0.76% 30
2022
Q4
$2.12M Sell
13,145
-145
-1% -$22.2K 0.76% 30
2022
Q3
$2.04M Buy
13,290
+2,494
+23% +$358K 0.83% 27
2022
Q2
$1.65M Sell
10,796
-2,371
-18% -$362K 0.79% 29
2022
Q1
$2.13M Sell
13,167
-1,338
-9% -$194K 0.74% 29
2021
Q4
$1.96M Buy
+14,505
New +$1.71M 0.69% 35

Other funds holding ABBV